This educational Whiteboard Snapshot program offers ophthalmologists and retina specialists an opportunity to recognize key patient factors that contribute to suboptimal initiation and adherence to anti-VEGF therapy in the management of nAMD, DME, and RVO. Through engaging whiteboard animations, participants will discover practical, evidence-based strategies to identify and overcome patient barriers, helping ensure equitable and optimal vision outcomes for patients living with retinal disease.

RELEASED DATE: December 10, 2025
EXPIRATION DATE: January 09, 2027

This program addresses disparities in patient care concerning the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). Participants will learn to identify key patient factors driving inadequate initiation of and adherence to anti-VEGF therapy. Through case studies, they will examine how racial, ethnic, and socioeconomic disparities elevate risks of vision loss, increase loss to follow up, and worsen visual outcomes. The program also underscores the critical need for a more diverse ophthalmology workforce to improve access to care.

RELEASED DATE: November 14, 2025
EXPIRATION DATE: November 14, 2026

This enduring activity targets healthcare gaps related to awareness of health disparities in the prevention and treatment of ocular diseases and the importance of diverse representation within clinical trials and the ophthalmology workforce, impacting outcomes through assessing for factors that can contribute to disparities in vision health and strategies to overcome them.

This online program targets critical issues in diabetic retinopathy, including the importance of screening and early detection of retinopathy, how early treatment in retinopathy can help prevent progression to vision-threatening complications, and the advantageous impact of multidisciplinary management in the care of a retinopathy patient. Learn essential elements of screening, referral, and treatment, as well as core systemic factors affecting risk for both development and worsening of diabetic eye disease, which when optimized can help preserve vision in diabetes.

This educational Fellows Focal Point whiteboard micromodule offers ophthalmology and retina specialty fellows an opportunity to understand how artificial intelligence (AI) may be used as a tool in the management of retinal disease. Learn about the potential role AI can play in supporting clinical decision making with anti-VEGF therapy, potential applications of AI across the patient journey, and considerations to effectively and safely incorporate AI into clinical workflow.

RELEASED DATE: April 11, 2025
EXPIRATION DATE: April 11, 2026

This educational Fellows Focal Point whiteboard micromodule offers ophthalmology and retina specialty fellows an opportunity to understand the impact of comorbidities and polypharmacy can have on people with retinal disease. Learn about the burden of comorbidities and polypharmacy, their associations with undertreatment or nonadherence in the management of retinal disease, along with strategies to help address these complex patients.

RELEASED DATE: May 16, 2025
EXPIRATION DATE: May 16, 2026

This educational Fellows Focal Point whiteboard micromodule offers ophthalmology and retina specialty fellows an opportunity to learn about the management of retinopathy of prematurity. Gain insight into the need for early detection and treatment, key considerations for laser photocoagulation, and the evolving role of anti-VEGF therapy in treating these babies.

RELEASED DATE: June 13, 2025
EXPIRATION DATE: June 13, 2026

This educational Fellows Focal Point whiteboard micromodule offers ophthalmology and retina specialty fellows an opportunity to learn about advances in the treatment of neovascular age-related macular degeneration and diabetic macular edema with anti-VEGF therapy. Gain insight into emerging evidence supporting the use of next-generation anti-VEGF agents, which have the potential to reduce treatment burden, enhance patient adherence, and improve vision outcomes across diverse patient profiles.

RELEASED DATE: July 11, 2025
EXPIRATION DATE: July 11, 2026

This enduring program about retinopathy of prematurity (ROP) targets key concepts about pathophysiology and the role of vascular endothelial growth factor (VEGF), screening, and management for this potentially visually blinding disorder of premature infants. Learn essential elements for recognizing infants at risk, timelines to ROP development, current advances in treatment approaches and critical examination timeframes to help prevent progression as well as complications of advanced disease.

This enduring activity targets healthcare gaps related to the early intervention of retinal vascular diseases and familiarity with new and emerging clinical trial data, impacting outcomes through assessment and synthesis of clinical trial structures, and outcomes of studied anti-VEGF agents for incorporation into treatment strategy development.